CRMD Cash-Secured Put Strategy
CRMD (CorMedix Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert catheter-related infections and blood clots in patients who utilize central venous catheters for medical procedures such as hemodialysis, total parenteral nutrition, and oncology care. Incorporated in 2006, the company initially operated as Picton Holding Company, Inc. until officially adopting the name CorMedix Inc. in January 2007. Its corporate headquarters are located in Berkeley Heights, New Jersey.
CRMD (CorMedix Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $615.8M, a trailing P/E of 3.45, a beta of 1.47 versus the broader market, a 52-week range of 6.13-14.96, average daily share volume of 1.3M, a public-listing history dating back to 2010, approximately 64 full-time employees. These structural characteristics shape how CRMD stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.47 indicates CRMD has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. The trailing P/E of 3.45 is on the value side, where IV often compresses outside event windows because forward growth expectations are already discounted into the share price.
What is a cash-secured put on CRMD?
A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.
Current CRMD snapshot
As of June 30, 2026, spot at $7.81, ATM IV 237.80%, IV rank 79.42%, expected move 68.18%. The cash-secured put on CRMD below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 52-day expiry.
Why this cash-secured put structure on CRMD specifically: CRMD IV at 237.80% is rich versus its 1-year range, which favors premium-selling structures like a CRMD cash-secured put, with a market-implied 1-standard-deviation move of approximately 68.18% (roughly $5.32 on the underlying). The 52-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CRMD expiries trade a higher absolute premium for lower per-day decay. Position sizing on CRMD should anchor to the underlying notional of $7.81 per share and to the trader's directional view on CRMD stock.
CRMD cash-secured put setup
The CRMD cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CRMD near $7.81, the first option leg uses a $7.42 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CRMD chain at a 52-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CRMD shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Put | $7.42 | N/A |
CRMD cash-secured put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.
CRMD cash-secured put payoff curve
Modeled P&L at expiration across a range of underlying prices for the cash-secured put on CRMD. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use cash-secured put on CRMD
Cash-secured puts on CRMD earn premium while a trader waits to acquire CRMD stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning CRMD.
CRMD thesis for this cash-secured put
The market-implied 1-standard-deviation range for CRMD extends from approximately $2.49 on the downside to $13.13 on the upside. A CRMD cash-secured put lets a trader earn premium while waiting to acquire CRMD at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current CRMD IV rank near 79.42% sits in the upper third of its 1-year distribution, which historically reverts; this raises the bar for premium-buying structures and lowers it for premium-selling structures on CRMD at 237.80%. As a Healthcare name, CRMD options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CRMD-specific events.
CRMD cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CRMD positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CRMD alongside the broader basket even when CRMD-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on CRMD carry tail risk when realized volatility exceeds the implied move; review historical CRMD earnings reactions and macro stress periods before sizing. Always rebuild the position from current CRMD chain quotes before placing a trade.
Frequently asked questions
- What is a cash-secured put on CRMD?
- A cash-secured put on CRMD is the cash-secured put strategy applied to CRMD (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With CRMD stock trading near $7.81, the strikes shown on this page are snapped to the nearest listed CRMD chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are CRMD cash-secured put max profit and max loss calculated?
- Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the CRMD cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 237.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CRMD cash-secured put?
- The breakeven for the CRMD cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CRMD market-implied 1-standard-deviation expected move is approximately 68.18%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a cash-secured put on CRMD?
- Cash-secured puts on CRMD earn premium while a trader waits to acquire CRMD stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning CRMD.
- How does current CRMD implied volatility affect this cash-secured put?
- CRMD ATM IV is at 237.80% with IV rank near 79.42%, which is elevated relative to its 1-year range. Premium-selling structures (covered call, cash-secured put, iron condor) generally look more attractive when IV rank is high; premium-buying structures (long call, long put, debit spreads) are more expensive in that regime.